بحث بيانات أعضاء هيئة التدريس - جامعة الزقازيق

ايمان احمد بهجت عساف

الموقع الشخصى

ايمان احمد بهجت عساف

الكلية الصيدلة - القسم الكيمياء التحليلية

الدرجات العلمية

بكالوريوس فى الكيمياء التحليليه, -جامعة الزقازيق [2007]
ماجستير فى الكيمياء التحليليه, -جامعة الزقازيق [2013]
(استحداث طرق تحليل آلي لتقدير بعض الادوية المخفضة لكل من ضغط الدم - السكر الدهون او بعض منها)
دكتوراه فى الكيمياء التحليليه, -جامعة الزقازيق [2019]
(التحليل الالي لبعض الادوية التي تعمل علي الجهاز العصبي المركزي)

التدرج الوظيفى الأكاديمى

معيد : 3/11/2007
مدرس مساعد : 1/12/2013
مدرس : 25/6/2019
أستاذ مساعد : 25/2/2025

الأبحاث العلمية

1 - Simple Atomic Absorption Spectroscopic and Spectrophotometric Methods for Determination of Pioglitazone Hydrochloride and Carvedilol in Pharmaceutical Dosage Forms (1435).

2 - HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC AND SPECTROPHOTOMETRIC DETERMINATIONS OF PIOGLITAZONE-HCl EITHER ALONE OR IN COMBINATION WITH METFORMIN-HCl (1433).

3 - A fast stability-indicating HPLC method for determination of sotalol hydrochloride in bulk powder and in dosage form (1437).

4 - Development of bioanalytical HPLC method for simultaneous determination of the antialzhiemer, donepezil hydrochloride and the antidepressant, citalopram hydrobromide in raw materials, spiked human plasma and tablets dosage form (1440).

5 - Bioanalytical HPLC method development for simultaneous determination of valsartan and co-administered clopidogrel bisulfate and fenofibrate in stroke prevention in raw materials, spiked human plasma and tablets (1440).

6 - Development of HPLC method coupled with fluorescence detection for simultaneous determination of donepezil HCl and trazodone HCl in spiked human plasma and tablets dosage forms (1440).

7 - MICRODETERMINATION OF CARVEDILOL AND ARIPIPRAZOLE USING HAEMATOXYLIN DYE IN PURE FORM AND PHARMACEUTICAL FORMULATIONS USING SPECTROPHOTOMETRY (1440).

8 - Spectrophotometric Microdetermination of Methyldopa and Etilefrine Hydrochloride using Copper (II)-Neocuproine Reagent in Pure Form and Pharmaceutical Formulations (1440).

9 - CONDUCTOMETRIC DETERMINATION OF LOSARTAN POTASSIUM USING PHOSPHOTUNGSTIC ACID, BROMOCRESOL PURPLE, MERCURY (II) CHLORIDE, AND CUPRIC CHLORIDE AS REAGENTS (1440).

10 - CONDUCTOMETRIC DETERMINATION OF THE TWO ANGIOTENSIN-CONVERTING ENZYME INHIBITORS, RAMIPRIL AND ENALAPRIL MALEATE IN PURE FORM AND IN TABLETS USING PHOSPHOTUNGSTIC ACID (1439).

11 - CONDUCTOMETRIC DETERMINATION OF THE TWO ANGIOTENSIN-CONVERTING ENZYME INHIBITORS, RAMIPRIL AND ENALAPRIL MALEATE IN PURE FORM AND IN TABLETS USING PHOSPHOTUNGSTIC ACID (1439).

12 - Development of a solvent-free micellar HPLC method for determination of five antidiabetic drugs using response surface methodology (1443).

13 - Magnetic iron oxide nanoparticles for HPLC determination of valsartan in aqueous environmental samples, biological samples and tablet dosage forms (1441).

14 - Development and validation of eco-friendly micellar organic solvent-free HPLC method for the simultaneous determination of some antihypertensive combinations (1443).

15 - A green spectrophotometric method for the simultaneous determination of nasal binary mixture used in respiratory diseases: Applying isosbestic point and chemometric approaches as a resolving tool, greenness evaluation (1444).

16 - The application of experimental design and green analytical chemistry in HPLC strategy for the determination of five drugs used in antimicrobial combination therapy (1444).

17 - Eco-friendly micellar HPLC approach for assessment of two anti-asthmatic breezhalers; Application of central composite design (1445).

18 - Green micelle and complex inclusion enhance synchronous spectrofluorimetric quantification of a novel analgesic combination: Tramadol and celecoxib in tablet dosage form and spiked human plasma (1445).

19 - Green Spectrophotometric Determination of Two Cephalosporin Drugs Used in COVID-19 Regimen Through Silver Nanoparticle Synthesis (1445).

20 - Analytical study on some antimicrobial and some CNS acting drugs (1445).

21 - Development of green micellar HPLC- DAD method for simultaneous determination of some sulbactam combinations used in COVID-19 regimen (1445).

22 - Stability-indicating HPLC-DAD and TLC-densitometry methods for the quantification of bupivacaine and meloxicam in their co-formulated mixture (1444).

23 - Manipulation and Processing of Spectral Signals for the Assay of the Newly Authorized Mixture of Bupivacaine/ Meloxicam Using Fully Green Solvents and a Comparative Green Evaluation Supporting the Greenness and Sustainability of the Developed Smart Spectrophotometric Methods (1444).

24 - HPLC-DAD technique for the quantification of a recently approved anti-diabetic triple combination along with two toxic official impurities: Toxicity confirmation aided by molecular docking application (1444).

25 - Exciting Advances in Sustainable Spectrophotometric Micro-Quantitation of an Innovative Painkiller “Tramadol and Celecoxib” Mixture in the Presence of a Toxic Impurity, Promoting Greenness and Whiteness Studies (1445).

26 - Challenging electroanalytical method for the determination of mirabegron in biological samples and pharmaceutical formulations (1445).

27 - Novel quantum dots-based assay for the determination of anti-hypertensive drugs minoxidil and timolol in different matrices (1446).

28 - Green HPLC technique development for the simultaneous determination of the potential combination of Mirabegron and Tamsulosin (1446).

29 - Eco-friendly spectrophotometric quantification of the potential combination of mirabegron and tamsulosin (1446).

المجالات البحثية

new instrumental methods for determination of some hypotensive, hypoglycemic and or some hypolipidemic agents